Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$31.66 - $38.9 $248,974 - $305,909
-7,864 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$30.45 - $39.36 $144,911 - $187,314
-4,759 Reduced 37.7%
7,864 $270,000
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $168,952 - $218,807
-5,893 Reduced 31.83%
12,623 $380,000
Q3 2021

Oct 28, 2021

SELL
$28.63 - $35.64 $322,631 - $401,627
-11,269 Reduced 37.83%
18,516 $610,000
Q2 2021

Jul 28, 2021

BUY
$28.45 - $38.0 $847,383 - $1.13 Million
29,785 New
29,785 $900,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.